Search
Champions Oncology Inc
CSBRAdd to Watchlist
5.055USD
-0.010-0.20%
Market hours （ET）Quotes delayed by 15 min
70.20MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-14No earnings forecast score is currently available for Champions Oncology Inc. The Biotechnology & Medical Research industry's average is 8.10. The average price target is 12.00, with a high of 12.00 and a low of 12.00.
Analyst Rating
Based on
0
analysts
--
Current Rating
12.000
Target Price
+109.42%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Champions Oncology Inc
CSBR
0
Beigene Ltd
ONC
28
argenx SE
ARGX
28
Ionis Pharmaceuticals Inc
IONS
25
IQVIA Holdings Inc
IQV
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Champions Oncology Inc's expected revenue for the next quarter?
Champions Oncology Inc's expected revenue is 15.04M.
What is Champions Oncology Inc's price target?
Analysts forecast that Champions Oncology Inc's price target is USD 12.00, with the highest forecast at USD 12.00 and the lowest forecast at USD 12.00.
How have Champions Oncology IncCSBR's recent earnings per share performed?
The market expectation was USD -0.05, while Champions Oncology IncCSBR's earnings per share (EPS) for the previous quarter was USD -0.02. EPS for the next quarter is expected at USD -0.01.